Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.0
7.8
Journals
Vaccines
Special Issues
Promoting Vaccination in the Post-COVID-19 Era
share announcement

Promoting Vaccination in the Post-COVID-19 Era

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: 30 June 2024 | Viewed by 4987

Special Issue Editor

Dr. Zoi Tsimtsiou

E-Mail Website
Guest Editor
Associate Professor, Department of Hygiene, Social-Preventive Medicine and Medical Statistics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Interests: public health; primary health care; health promotion; vaccination hesitancy; quality of healthcare

Special Issue Information

Dear Colleagues,  

We are pleased to invite you to contribute to a Special Issue on the factors to consider in the global effort to promote vaccination in the post-COVID-19 era. 

Although vaccination is one of the most cost-effective ways of preventing disease, vaccine hesitancy has been included among the ten threats of global health, and vaccination coverage remains globally suboptimal, especially among adults. During the pandemic, numerous changes occurred that may contribute either positively or negatively to promoting vaccination in the era that follows. Although new challenges to vaccine acceptance have arisen following the introduction of the COVID-19 vaccines, the pandemic may have also acted as a golden opportunity for raising awareness on prevention issues in the population. In an effort to develop interventions that increase vaccination coverage in the post-pandemic era, investigating what people think and feel, as well as social influences and practical factors that may affect their motivation and ability to get vaccinated, is essential. 

To achieve a more extensive understanding of the different factors that should be taken into consideration to deal effectively with suboptimal vaccination coverage in the post-COVID-19 era, this Special Issue is focused on the studies made in this field. Based on your extensive knowledge and experience, we invite you to contribute recent studies that present people’s attitudes, knowledge, fears, and expectations concerning vaccination, as well as social influences and practical factors that may affect vaccination uptake, in order to inform interventions effectively for the promotion of vaccination in the post-COVID-19 era globally.

Dr. Zoi Tsimtsiou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccination
  • coverage
  • hesitancy
  • attitudes
  • behaviors
  • interventions
  • health promotion
  • public health
  • primary health care
  • barriers

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Other

15 pages, 2695 KiB  
Article
Diphtheria and Tetanus Immunity Status among Greek Adults: Results from a Nationwide Seroprevalence Study
by Dimitrios Papagiannis, Eleftherios Thireos, Anargiros Mariolis, Antonios Katsioulis, Ioannis Ch. Lampropoulos, Ioanna Tsiaousi, Kostantina Gartzonika, Niki Malliaraki, Foteini Malli, Erasmia C. Rouka, Georgios Marinos, Emmanouil K. Symvoulakis, Georgios Rachiotis and Konstantinos I. Gourgoulianis
Vaccines 2024, 12(4), 378; https://doi.org/10.3390/vaccines12040378 - 02 Apr 2024
Viewed by 602
Abstract
Diphtheria and tetanus could lead to serious morbidity. We aimed to evaluate immunity levels by measuring specific IgG antibodies for diphtheria and tetanus in serum samples from a nationally expanded sample of the Greek population. A geographically stratified sampling approach based on regional [...] Read more.
Diphtheria and tetanus could lead to serious morbidity. We aimed to evaluate immunity levels by measuring specific IgG antibodies for diphtheria and tetanus in serum samples from a nationally expanded sample of the Greek population. A geographically stratified sampling approach based on regional units (NUTS level 2) was applied by considering variables such as age group (30–80+) and sex. In total, 1201 persons (47.7% males and 52.3% females) participated in the survey. Bivariate analysis revealed a negative relationship between diphtheria and tetanus median antibody titers and age. The overall seropositivity rate for diphtheria IgG antibodies (≥0.10 IU/mL) was estimated at 31.5%. Regarding tetanus, the total seropositivity rate was estimated at 59.5% (tetanus IgG antibodies ≥0.10 IU/mL). Logistic regression analysis indicated that age groups <40 years and 40–59 years were independently associated with tetanus seropositivity. Logistic regression also revealed that male sex and being aged 60–69 years were independent risk factors for diphtheria-related seropositivity. Lastly, being resident of some regions was an independent risk factor for both diphtheria- and tetanus-related seropositivity. The present study shows that Greek adults are still not completely immune to diphtheria and tetanus. It is likely possible to achieve optimal immunization coverage by implementing serviceable public health initiatives after comprehending real community needs. Full article
(This article belongs to the Special Issue Promoting Vaccination in the Post-COVID-19 Era)
►▼ Show Figures

Figure 1

18 pages, 287 KiB  
Article
Exploring Perceptions and Practices Regarding Adult Vaccination against Seasonal Influenza, Tetanus, Pneumococcal Disease, Herpes Zoster and COVID-19: A Mixed-Methods Study in Greece
by Iordanis Avramidis, Ilias Pagkozidis, Philippe-Richard J. Domeyer, Georgios Papazisis, Ilias Tirodimos, Theodoros Dardavesis and Zoi Tsimtsiou
Vaccines 2024, 12(1), 80; https://doi.org/10.3390/vaccines12010080 - 12 Jan 2024
Viewed by 1423
Abstract
We aimed to document vaccination coverage for five vaccines, predictors of each vaccine’s uptake and attitudes regarding adult vaccination. Adults visiting four pharmacies were randomly invited to participate during summer 2022. Among 395 participants (mean age 51.2 years, range 19–96), vaccination rates were [...] Read more.
We aimed to document vaccination coverage for five vaccines, predictors of each vaccine’s uptake and attitudes regarding adult vaccination. Adults visiting four pharmacies were randomly invited to participate during summer 2022. Among 395 participants (mean age 51.2 years, range 19–96), vaccination rates were 78.1% for influenza and 25.8% for herpes zoster (≥60 years old), 64.3% for pneumococcal disease (≥65 years old), 33.1% for tetanus, while 11.4% had received two and 74.8% ≥3 COVID-19 vaccine doses. Half of participants (50.1%) voiced some degree of hesitancy, and 1.3% were refusers. The strongest predictor of each vaccine’s uptake was doctor’s recommendation (OR range 11.33–37.66, p < 0.001) and pharmacist’s recommendation (4.01–19.52, p < 0.05), except for the COVID-19 vaccine, where the Attitude Towards Adult VACcination (ATAVAC) value of adult vaccination subscale’s score was the only predictor (OR: 5.75, p < 0.001). Regarding insufficient coverage, thematic content analysis revealed seven main themes. Insufficient knowledge, the absence of health professionals’ recommendation, perception of low susceptibility to disease, negligence and dispute of vaccine effectiveness were universal themes, whereas safety concerns and distrust in authorities were reported solely for COVID-19 vaccination. Designing public interventions aiming to increase trust in adult vaccination is essential in the aftermath of the COVID-19 pandemic. Health professionals’ role in recommending strongly adult vaccination is crucial. Full article
(This article belongs to the Special Issue Promoting Vaccination in the Post-COVID-19 Era)
15 pages, 1298 KiB  
Article
Psychological Factors of Vaccination Intent among Healthcare Providers, Parents, and Laypeople
by Kaja Damnjanović, Sandra Ilić, Marija Kušić, Milica Lazić and Dragoslav Popović
Vaccines 2023, 11(12), 1816; https://doi.org/10.3390/vaccines11121816 - 04 Dec 2023
Cited by 1 | Viewed by 1220
Abstract
The interrelatedness of social-structural aspects and psychological features with vaccination intention provides the context to explore personal psychological features related to vaccination. Specifically, we focused on general decision making and vaccine-related dispositions, and their contribution to the intention to vaccinate, within post-pandemic circumstances, [...] Read more.
The interrelatedness of social-structural aspects and psychological features with vaccination intention provides the context to explore personal psychological features related to vaccination. Specifically, we focused on general decision making and vaccine-related dispositions, and their contribution to the intention to vaccinate, within post-pandemic circumstances, after the imposed possibility of choosing a vaccine brand. Our study aimed to map the function (promotive, protective, risk, vulnerability) of a set of personal psychological aspects in the intention to vaccinate among people holding different social roles regarding the vaccination. We surveyed three samples of people: healthcare providers (HPs), parents, and laypeople, within the post-pandemic context. Negative vaccine attitudes lower intention to vaccinate in all regression models (all βs ranging from −0.128 to −0.983, all ps < 0.01). The main results indicate that, regardless of the sample/social role, there is a shared attitudinal core for positive vaccination intention. This core consists of [high] trust in large corporations, government, and healthcare systems, as well as perceived consensus on vaccine safety/efficacy and experience of freedom (protective factors), and [low] vaccination conspiracy beliefs, trust in social media, and choice overload (risk and vulnerability factors, respectively). There are no common promotive factors of intention to vaccinate: for parents, perceived consensus on vaccines, and trust in corporations and the healthcare system, play such roles; for HPs, the experience of freedom is obtained as a unique promotive factor. In contrast, for laypeople, no unique promotive factors were found. Our findings provide insights into the function of psychological factors of vaccination intention across different social roles, particularly healthcare providers, parents, and laypeople, and emphasize the need for tailored immunization interventions in the post-pandemic landscape. Full article
(This article belongs to the Special Issue Promoting Vaccination in the Post-COVID-19 Era)
►▼ Show Figures

Figure 1

Other

Jump to: Research

11 pages, 838 KiB  
Project Report
Key Learnings from the Development and Early Use of Global Guidance on the Integration of COVID-19 Vaccination into Broader Health Systems
by Ibrahim Dadari, Alba Vilajeliu, Viorica Berdaga, Shalini Rozario, Phoebe Meyer, Laura Nic Lochlainn, Dirk Horemans, Nuria Toro, Gloria Lihemo, Sanjay Bhardwaj, Peter Cowley, Diana Chang Blanc, Florence Conteh-Nordman, Imran Mirza, Shahira Malm, Ida Marie Ameda and Ann Lindstrand
Vaccines 2024, 12(2), 196; https://doi.org/10.3390/vaccines12020196 - 14 Feb 2024
Viewed by 1013
Abstract
More than 13.5 billion COVID-19 vaccine doses were delivered between 2021 and 2023 through a mix of delivery platforms, with mass vaccination campaigns being the main approach. In 2022, with the continued circulation of SARS-CoV2 and the need for periodic boosters being most [...] Read more.
More than 13.5 billion COVID-19 vaccine doses were delivered between 2021 and 2023 through a mix of delivery platforms, with mass vaccination campaigns being the main approach. In 2022, with the continued circulation of SARS-CoV2 and the need for periodic boosters being most likely, countries were required to plan for more sustainable approaches to provide COVID-19 vaccinations. In this context of uncertainty, a global tool for integrating COVID-19 vaccines into immunization programs and as part of broader health systems was published jointly by the WHO and UNICEF to respond to country needs. This paper summarizes the approach to, and lessons learned during, the development of a global guidance document and describes some examples of its early use in low- and middle-income countries (LMICs). The guidance leveraged existing health system frameworks, proposed four steps for planning and implementing the COVID-19 vaccination integration journey, and identified investment areas. The development process maximized robust global stakeholder and country engagement, and the timeframe was aligned with donor funding windows to support countries with the integration of COVID-19 vaccination. The rapid dissemination of the guidance document allowed countries to ascertain their readiness for integrating COVID-19 vaccination and inform the development of national plans and funding applications. While progress has been made in specific areas (e.g., optimizing cold chain and logistics leveraging COVID-19 vaccination), in the context of decreasing demand for COVID-19 vaccines, reaching adult COVID-19 vaccine high-priority-use groups and engaging and coordinating with other health programs (beyond immunization) remain challenges, particularly in LMICs. We share the learning that despite the uncertainties of a pandemic, guidance documents can be developed and used within a short timeframe. Working in partnership with stakeholders within and beyond immunization towards a common objective is powerful and can allow progress to be made in terms of integrating health services and better preparing for future pandemics. Full article
(This article belongs to the Special Issue Promoting Vaccination in the Post-COVID-19 Era)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop